Resultados de la búsqueda 311-320 of 17174 for Menopause Management
OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis. Rochester, Minn. The purpose of this study is to determine if Obinutuzumab is effective and safe in ...
Rochester, Minn. This study is designed to: -analyze effects of surgical treatment -improve surgical care and quality of life of patients with hip problems/ ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization ...
... treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) ... Most newly-diagnosed CLL patients have early-stage disease at the time of ...
junio 2025. Mayo Clinic Q and A: What are your options for managing BPH? ... Consumer Health: What does 'male menopause' mean? Dec. 25, 2023, 01:00 p.m. ...
Rochester, Minn. The purpose of this study is to describe the outcome and complications in surgical management of Preiser',s disease in the past 30 years in the ...
The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...
Stress management: Learn why you feel stress and how to fight it.
The aim of this study is to study the efficacy and safety of our short and long one-day protocols for TMP-SMX graded administration in hematologic ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?